ReviewGenes2026
Forensic Body Fluid RNA Typing: Evaluating the Roles of CE and dPCR Technologies.
Review in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The identification of body fluids in forensic science has increasingly relied on RNA-based approaches due to their tissue specificity and ability to provide probative information beyond DNA profiling. Among the analytical platforms used for RNA detection, capillary electrophoresis (CE) has traditionally served as the standard method in forensic laboratories, offering established workflows and effective multiplexing capabilities. However, recent studies in digital PCR (dPCR) have introduced a highly sensitive alternative that enables absolute quantification of target transcripts without reliance on standard curves, particularly beneficial for low-template and degraded forensic samples. This short review provides a focused comparative evaluation of CE- and dPCR-based workflows for RNA-based body fluid identification, emphasizing analytical performance and forensic applicability. Key parameters, including sensitivity, specificity, multiplexing capacity, tolerance to degraded RNA, and interpretation methods, are critically assessed. CE remains advantageous for multiplex assay design and routine forensic implementation due to its established infrastructure and throughput. In contrast, dPCR demonstrates superior sensitivity and quantitative precision, particularly in challenging forensic samples, but is currently limited by reduced multiplexing capacity and higher costs. The review highlights the methodological strengths and limitations of both platforms and examines their suitability for forensic casework. Overall, CE and dPCR are not positioned as competing replacements at the moment but rather as complementary technologies, with their combined or context-dependent use offering improved robustness in RNA-based forensic body fluid identification. Further validation and standardization studies are required to support broader implementation of dPCR in routine forensic workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.